Partnership for preventing HPV-related cancers in HIV-positive populations
California-Mexico-Puerto Rico Partnership (CAMPO) Center for Prevention of HPV-related Cancer in HIV+ Populations
['FUNDING_OTHER'] · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · NIH-10900775
This study is looking for better ways to find and manage HPV-related cancers, like cervical and anal cancers, in people living with HIV in Mexico and Puerto Rico, by testing new screening methods to catch any early signs of these cancers.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO (nih funded) |
| Locations | 1 site (SAN FRANCISCO, UNITED STATES) |
| Trial ID | NIH-10900775 on ClinicalTrials.gov |
What this research studies
This research focuses on improving the early detection and management of HPV-related cancers, particularly cervical and anal cancers, in HIV-positive individuals in Mexico and Puerto Rico. The project will evaluate new screening methods, including advanced testing for high-risk HPV and other biomarkers, to identify precancerous lesions in both women and men. By conducting clinical studies with a large number of participants, the research aims to develop effective strategies for screening and treatment that are tailored to the needs of this population.
Who could benefit from this research
Good fit: Ideal candidates for participation include HIV-positive women and men, particularly those living in Mexico and Puerto Rico, who are at risk for HPV-related cancers.
Not a fit: Patients who are not HIV-positive or those who do not reside in the targeted geographic areas may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to better screening and treatment options for HPV-related cancers in HIV-positive individuals, ultimately reducing morbidity and mortality in this vulnerable population.
How similar studies have performed: Previous research has shown promise in using advanced screening technologies for HPV detection in similar populations, indicating that this approach could be effective.
Where this research is happening
SAN FRANCISCO, UNITED STATES
- UNIVERSITY OF CALIFORNIA, SAN FRANCISCO — SAN FRANCISCO, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: PALEFSKY, JOEL MICHAEL — UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
- Study coordinator: PALEFSKY, JOEL MICHAEL
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Acquired Immune Deficiency Syndrome Virus, Acquired Immunodeficiency Syndrome Virus, Anal Cancer, Anal Cancers